MARKET

LEGN

LEGN

Legend Biotech Corp
NASDAQ
17.91
+0.72
+4.19%
After Hours: 17.91 0 0.00% 19:49 02/10 EST
OPEN
17.38
PREV CLOSE
17.19
HIGH
18.14
LOW
17.20
VOLUME
2.78M
TURNOVER
--
52 WEEK HIGH
45.30
52 WEEK LOW
16.24
MARKET CAP
3.31B
P/E (TTM)
-13.7568
1D
5D
1M
3M
1Y
5Y
1D
How Legend Biotech’s Boardroom Shake-Up and New Audit Chair Will Impact Legend Biotech (LEGN) Investors
Simply Wall St · 1d ago
Weekly Report: what happened at LEGN last week (0202-0206)?
Weekly Report · 1d ago
Legend Biotech (LEGN) Valuation Check As Board Changes And CARVYKTI Sales Update Draw Attention
Simply Wall St · 3d ago
Legend Biotech Names Veteran Finance Executive Gareth Kung to Board and Audit Chair Role
TipRanks · 4d ago
Legend Biotech beruft Gareth Kung in den Vorstand
Reuters · 4d ago
Legend Biotech Appoints Gareth Kung to Board and Audit Committee Chair
Reuters · 4d ago
Why Investors Shouldn't Be Surprised By Legend Biotech Corporation's (NASDAQ:LEGN) 26% Share Price Plunge
Simply Wall St · 4d ago
Legend Biotech Is Maintained at Overweight by Barclays
Dow Jones · 6d ago
More
About LEGN
Legend Biotech Corporation is a global biopharmaceutical company. The Company is engaged in the discovery, development, manufacturing and commercialization of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.

Webull offers Legend Biotech Corp (ADR) stock information, including NASDAQ: LEGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LEGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LEGN stock methods without spending real money on the virtual paper trading platform.